Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Kyu Lee

Showing results (501-510 of 522) with videos related to

Pageof 53
Sort By:
Scientific Reports|November 13, 2015
Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 PhosphorylationSun Joo Lee, Ji Yun Jeong, Chang Joo Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Upregulation of the ERRγ-VDAC1 axis underlies the molecular pathogenesis of pancreatitisDipanjan Chanda, Themis Thoudam, Ibotombi Singh Sinam, et al.
Circulation Research|July 13, 2014
Small heterodimer partner blocks cardiac hypertrophy by interfering with GATA6 signalingYoon Seok Nam, Yoojung Kim, Hosouk Joung, et al.
Diabetes|July 8, 2016
Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and KetogenesisYounghoon Go, Ji Yun Jeong, Nam Ho Jeoung, et al.
Cell Metabolism|November 2, 2010
A liver-derived secretory protein, selenoprotein P, causes insulin resistanceHirofumi Misu, Toshinari Takamura, Hiroaki Takayama, et al.
Kidney International|July 3, 2023
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusionChang Joo Oh, Min-Ji Kim, Ji-Min Lee, et al.
Endocrine Journal|March 31, 2015
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetesHae Kyung Yang, Kyung Wan Min, Sung Woo Park, et al.
Autophagy|May 14, 2020
Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in miceMyoung Seok Ko, Ji Young Yun, In-Jeoung Baek, et al.
Diabetes & Metabolism Journal|January 4, 2019
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialTae Jung Oh, Jae Myung Yu, Kyung Wan Min, et al.
Journal of Medicinal Chemistry|January 19, 2019
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid CancerJina Kim, Jaeyoung Song, Hyun Dong Ji, et al.
Pageof 53

Showing results (501-510 of 522) with videos related to

Sort By:
Pageof 53
Scientific Reports|November 13, 2015
Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 PhosphorylationSun Joo Lee, Ji Yun Jeong, Chang Joo Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Upregulation of the ERRγ-VDAC1 axis underlies the molecular pathogenesis of pancreatitisDipanjan Chanda, Themis Thoudam, Ibotombi Singh Sinam, et al.
Circulation Research|July 13, 2014
Small heterodimer partner blocks cardiac hypertrophy by interfering with GATA6 signalingYoon Seok Nam, Yoojung Kim, Hosouk Joung, et al.
Diabetes|July 8, 2016
Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and KetogenesisYounghoon Go, Ji Yun Jeong, Nam Ho Jeoung, et al.
Cell Metabolism|November 2, 2010
A liver-derived secretory protein, selenoprotein P, causes insulin resistanceHirofumi Misu, Toshinari Takamura, Hiroaki Takayama, et al.
Kidney International|July 3, 2023
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusionChang Joo Oh, Min-Ji Kim, Ji-Min Lee, et al.
Endocrine Journal|March 31, 2015
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetesHae Kyung Yang, Kyung Wan Min, Sung Woo Park, et al.
Autophagy|May 14, 2020
Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in miceMyoung Seok Ko, Ji Young Yun, In-Jeoung Baek, et al.
Diabetes & Metabolism Journal|January 4, 2019
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialTae Jung Oh, Jae Myung Yu, Kyung Wan Min, et al.
Journal of Medicinal Chemistry|January 19, 2019
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid CancerJina Kim, Jaeyoung Song, Hyun Dong Ji, et al.
Pageof 53